Janux Therapeutics, Inc. - Common Stock (NQ:JANX)
Price and Volume
Detailed Quote| Volume | 36,685 |
| Open | 16.46 |
| Bid (Size) | 16.24 (500) |
| Ask (Size) | 16.27 (200) |
| Prev. Close | 16.26 |
| Today's Range | 16.21 - 16.53 |
| 52wk Range | 12.12 - 35.34 |
| Shares Outstanding | 41,833,315 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Options Exercise: Janux Executive Sells 16,665 Shares for $501,000 ↗
December 04, 2025
Which stocks are moving on Tuesday? ↗
December 02, 2025
Which stocks are gapping on Tuesday? ↗
December 02, 2025
These stocks are moving in today's pre-market session ↗
December 02, 2025
What's going on in today's after hours session ↗
December 01, 2025
Janux (JANX) R&D Soars Revenue Misses ↗
August 07, 2025
Frequently Asked Questions
Is Janux Therapeutics, Inc. - Common Stock publicly traded?
Yes, Janux Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Janux Therapeutics, Inc. - Common Stock trade on?
Janux Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Janux Therapeutics, Inc. - Common Stock?
The ticker symbol for Janux Therapeutics, Inc. - Common Stock is JANX on the Nasdaq Stock Market
What is the current price of Janux Therapeutics, Inc. - Common Stock?
The current price of Janux Therapeutics, Inc. - Common Stock is 16.26
When was Janux Therapeutics, Inc. - Common Stock last traded?
The last trade of Janux Therapeutics, Inc. - Common Stock was at 07/20/26 09:53 AM ET
What is the market capitalization of Janux Therapeutics, Inc. - Common Stock?
The market capitalization of Janux Therapeutics, Inc. - Common Stock is 680.21M
How many shares of Janux Therapeutics, Inc. - Common Stock are outstanding?
Janux Therapeutics, Inc. - Common Stock has 680M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube